JP2016527264A5 - - Google Patents

Download PDF

Info

Publication number
JP2016527264A5
JP2016527264A5 JP2016530646A JP2016530646A JP2016527264A5 JP 2016527264 A5 JP2016527264 A5 JP 2016527264A5 JP 2016530646 A JP2016530646 A JP 2016530646A JP 2016530646 A JP2016530646 A JP 2016530646A JP 2016527264 A5 JP2016527264 A5 JP 2016527264A5
Authority
JP
Japan
Prior art keywords
hyaluronic acid
composition
salt
mepivacaine
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016530646A
Other languages
English (en)
Japanese (ja)
Other versions
JP6543625B2 (ja
JP2016527264A (ja
Filing date
Publication date
Priority claimed from US13/954,360 external-priority patent/US9421198B2/en
Application filed filed Critical
Publication of JP2016527264A publication Critical patent/JP2016527264A/ja
Publication of JP2016527264A5 publication Critical patent/JP2016527264A5/ja
Application granted granted Critical
Publication of JP6543625B2 publication Critical patent/JP6543625B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016530646A 2013-07-30 2014-07-29 ヒアルロン酸およびメピバカインを含む組成物 Active JP6543625B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/954,360 US9421198B2 (en) 2013-07-30 2013-07-30 Composition comprising hyaluronic acid and mepivacaine
US13/954,360 2013-07-30
PCT/IB2014/063503 WO2015015407A1 (en) 2013-07-30 2014-07-29 Composition comprising hyaluronic acid and mepivacaine

Publications (3)

Publication Number Publication Date
JP2016527264A JP2016527264A (ja) 2016-09-08
JP2016527264A5 true JP2016527264A5 (enExample) 2017-08-03
JP6543625B2 JP6543625B2 (ja) 2019-07-10

Family

ID=51570796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016530646A Active JP6543625B2 (ja) 2013-07-30 2014-07-29 ヒアルロン酸およびメピバカインを含む組成物

Country Status (21)

Country Link
US (9) US9421198B2 (enExample)
EP (2) EP3574901B1 (enExample)
JP (1) JP6543625B2 (enExample)
KR (2) KR20160038047A (enExample)
CN (2) CN113648459A (enExample)
AU (1) AU2014298046B2 (enExample)
BR (1) BR112016002171A2 (enExample)
CA (1) CA2919792C (enExample)
CY (1) CY1122648T1 (enExample)
DK (2) DK3574901T3 (enExample)
ES (2) ES2743755T3 (enExample)
HR (1) HRP20191345T1 (enExample)
HU (1) HUE045969T2 (enExample)
LT (1) LT3027186T (enExample)
PL (2) PL3574901T3 (enExample)
PT (2) PT3027186T (enExample)
RS (1) RS59108B1 (enExample)
RU (1) RU2670617C2 (enExample)
SI (1) SI3027186T1 (enExample)
SM (1) SMT201900494T1 (enExample)
WO (1) WO2015015407A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9421198B2 (en) 2013-07-30 2016-08-23 Teoxane Composition comprising hyaluronic acid and mepivacaine
FR3015290B1 (fr) * 2013-12-23 2017-01-13 Lab Vivacy Compositions d'acide hyaluronique compreant de la mepivacaine
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
FR3036035B1 (fr) 2015-05-11 2018-10-05 Laboratoires Vivacy Compositions comprenant au moins un polyol et au moins un anesthesique
EP3165233B1 (en) * 2015-08-28 2021-08-18 Latvijas Universitate Biomaterial for treatment of acute and chronic skin wounds
FR3058064B1 (fr) 2016-10-28 2020-08-07 Lab Vivacy Composition a base d'acide hyaluronique comprenant de la mepivacaine
EP3354258A1 (en) * 2017-01-31 2018-08-01 Teoxane SA Use of a cohesive gel as a matrix material in a periodontal pocket
TWI716671B (zh) * 2017-02-28 2021-01-21 南韓商Ｃｇ生物技術有限公司 皮膚注射用組成物
EP3609483A4 (en) * 2017-04-12 2021-01-20 Urigen Pharmaceuticals, Inc. Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability
KR102091452B1 (ko) * 2017-12-19 2020-03-20 대화제약 주식회사 국소 마취제 및 히알루론산 하이드로겔을 포함하는 사전충전형 주사기의 제조방법
US11534385B2 (en) * 2017-12-29 2022-12-27 Matex Lab S.P.A. Method to prepare a filler with hyaluronic acid base comprising a neutralization step
AU2019218711B2 (en) 2018-02-06 2024-12-05 Regen Lab Sa Cross-linked hyaluronic acids and combinations with PRP/BMC
CN110721142A (zh) * 2018-07-17 2020-01-24 上海美白臻生物科技有限公司 一种全效型微整专用玻尿酸制备工艺
ES3041267T3 (en) * 2018-12-20 2025-11-11 Lg Chemical Ltd Filler having excellent filler properties comprising hyaluronic acid hydrogel
EP3969057B1 (en) 2019-05-17 2025-12-17 The Governing Council of the University of Toronto Sustained release local anesthetic hydrogel composition
US12414917B2 (en) 2019-09-13 2025-09-16 University Of Utah Research Foundation Opioid independent surgical anesthetic
FR3105729B1 (fr) * 2019-12-31 2023-07-21 Mrs Biotech Composition pour la gestion du poids d’un sujet
EP3861996A1 (en) 2020-02-04 2021-08-11 I+Med S. Coop. Controlled release system of phytocannabinoids formulations soluble in aqueous media, methods and uses thereof
TWI731660B (zh) * 2020-04-24 2021-06-21 透策生技股份有限公司 利用加壓手段以加速注射式填充物分散的處理方法
WO2022038474A1 (en) * 2020-08-18 2022-02-24 Innate S.R.L. Injectable composition and use of said composition
KR20240105428A (ko) * 2021-11-10 2024-07-05 아이메이커 테크놀러지 디벨롭먼트 캄파니 리미티드 겔 재료 및 이의 제조 방법과 응용
CN113896915B (zh) * 2021-11-10 2024-02-13 爱美客技术发展股份有限公司 一种凝胶材料及其制备方法与应用
WO2023158281A1 (ko) * 2022-02-21 2023-08-24 이광미 금속 티오옥토일 히알루로네이트 복합체 및 그의 용도
KR102451308B1 (ko) * 2022-02-21 2022-10-07 이광미 금속 티오옥토일 히알루로네이트 복합체 및 이의 제조 방법
KR102559788B1 (ko) * 2022-04-21 2023-07-27 주식회사 티앤알바이오팹 다단계 탈세포화된 조직 매트릭스 및 이의 제조방법
CN117357699B (zh) * 2022-07-06 2024-12-10 渼颜空间(河北)生物科技有限公司 一种具有祛斑功效的透明质酸钠组合物及其制备方法和其应用
CN115737506B (zh) * 2022-12-16 2023-09-05 江苏亨瑞生物医药科技有限公司 一种含有胶原蛋白的面膜及其制备方法
KR102680817B1 (ko) * 2023-06-02 2024-07-03 주식회사 에스씨엘 히알루론산 필러의 제조방법

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799679A (en) 1955-04-28 1957-07-16 Bofors Ab Process of preparing amides of heterocyclic carboxylic acids
GB826668A (en) 1955-06-27 1960-01-20 Crookes Lab Ltd Process for manufacturing basic carboxamides
IT1303735B1 (it) 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
DE10246340A1 (de) 2002-10-04 2004-04-29 Wohlrab, David, Dr. Kombinationspräparat aus Hyaluronsäure und mindestens einem Lokalanästhetikum und dessen Verwendung
US8124120B2 (en) 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
MXPA06007556A (es) 2003-12-30 2006-08-31 Genzyme Corp Geles cohesivos de hialuronano y/o hilano entrecruzados, su preparacion y su uso.
CN1930178B (zh) 2004-01-23 2010-06-23 俄亥俄州立大学 Pgg的分离和纯化
CN101056891B (zh) * 2004-11-15 2010-05-26 株式会社资生堂 交联透明质酸凝胶的制备方法
US8092730B2 (en) 2005-12-06 2012-01-10 Entegris, Inc. Molded rotatable base for a porous pad
BRPI0913189A2 (pt) 2008-05-30 2016-01-12 Allergan Inc dispositivo de injeção para cargas de aumento de tecido mole, agentes bioativos e outros materiais biocompatíveis em forma líquida ou gel
US8450475B2 (en) * 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
FR2945293B1 (fr) 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
WO2010136594A2 (en) * 2009-05-29 2010-12-02 Symatese Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
US20110171310A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
US20110171286A1 (en) 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
FR2962040B3 (fr) 2010-07-05 2012-08-10 Alain Villette Composition injectable comprenant un medicament injectable et un gel
EP4616907A3 (en) 2010-11-08 2025-11-12 Allergan Industries, SAS Soft tissue filler
EP2484387A1 (en) 2011-02-03 2012-08-08 Q-Med AB Hyaluronic acid composition
EP2606828B1 (en) 2011-12-20 2018-04-11 Angioclinic AG Hyaluronic acid and its use for treating venous insufficiency and varicose veins
US9241921B2 (en) * 2011-05-02 2016-01-26 Pankaj Modi Photosensitizer composition for treating skin disorders
ES2738208T3 (es) * 2011-06-03 2020-01-20 Allergan Ind Sas Composiciones de relleno dérmico que incluyen antioxidantes
FR2979539B1 (fr) 2011-09-05 2013-09-27 Teoxane Composition sterile dermo-injectable
US20130131632A1 (en) 2011-11-18 2013-05-23 Allergan, Inc. Injection device and method for diluting an injectable fluid
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
CN102805882B (zh) * 2012-08-28 2014-04-23 华熙福瑞达生物医药有限公司 一种软组织填充剂在使用前与麻醉剂注射液混合的方法
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
JP2016503013A (ja) * 2012-12-13 2016-02-01 プレシジョン ダーマトロジー インコーポレイテッドＰｒｅｃｉｓｉｏｎ Ｄｅｒｍａｔｏｌｏｇｙ， Ｉｎｃ． ヒアルロン酸の皮膚濃度を増加させるための局所製剤
WO2014165113A1 (en) 2013-03-12 2014-10-09 Allergan Holdings France S.A.S. Cross-linked hyaluronic acid threads for treatment of striae
US9421198B2 (en) 2013-07-30 2016-08-23 Teoxane Composition comprising hyaluronic acid and mepivacaine
FR3015290B1 (fr) 2013-12-23 2017-01-13 Lab Vivacy Compositions d'acide hyaluronique compreant de la mepivacaine

Similar Documents

Publication Publication Date Title
JP2016527264A5 (enExample)
RU2016106152A (ru) Композиция, содержащая гиалуроновую кислоту и мепивакаин
BRPI0917588A2 (pt) Método de preparação de uma composição de enchimento de tecido mole
JP2010511454A5 (ja) 皮内注射用ヒアルロン酸ゲル移植片
NZ610346A (en) Hyaluronic acid based formulations
WO2004073759A1 (en) Composition and method for intradermal soft tissue augmentation
RU2014122994A (ru) Пленкообразующие композиции для зубов
JP2018504448A5 (enExample)
JP6847866B2 (ja) コンドロイチン硫酸及びヒアルロン酸を含有する安定化された水性組成物
RU2017131027A (ru) Композиции и способы для улучшения внешнего вида кожи
CN104398390B (zh) 牙本质底涂‑冲洗底涂剂及其方法
GEP20115348B (en) Pharmaceutical composition for treating burns (variants) and methods for the production thereof (variants)
EA202192925A1 (ru) Твердые формы ингибитора glyt1
CY1115908T1 (el) Υγρη συνταγοποιηση προϊοντος συζευξης g-csf
JP2010047494A (ja) 歯牙塗布用組成物
EA201790382A1 (ru) Способы лечения периимплантита
MX2019003206A (es) Gel de acido hialuronico con un cation de zinc divalente.
PH12020551117A1 (en) Compositions for preventing or treating uveitis
CY1125257T1 (el) Αντισηπτικη συνθεση που περιλαμβανει ουνιθειολη και διμεθυλσουλφοξειδιο, χρηση της συνθεσης και μεθοδος περιποιησης τραυματων με τη χρηση του
ZA202102412B (en) Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2- dithiole-3-thiones
WO2021111426A3 (en) Histatin-1 formulation for the treatment, repair or regeneration of bone tissue in a subject
RU2589840C1 (ru) Гидрофильный гель для раневого покрытия
PH12020551620A1 (en) Compositions for preventing or treating dry eye
Harikumar et al. Collagen-chitosan barrier membrane, a novel indigenous and economic material for management of periodontal infrabony defects-a case-control studyl
RU2018123962A (ru) Инъецируемые композиции дермальных наполнителей